Lunai Bioworks Inc. (LNAI) Income Statement
LNAI FY2026 at a glance
Fiscal year ended June 30, 2026 · U.S. dollarsLNAI revenue and net income
Where LNAI's revenue goes
FY2026Each bar shows an amount and its share of revenue. LNAI kept −6,851,975.3% of revenue as net income.
LNAI profit margins
LNAI growth rates
to FY2026| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
LNAI quarterly EPS vs estimates
Next report: November 13, 2026.
LNAI income statement
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | $51,992 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $93,522 | $129,094 | $0 | $0 | — | $391,416 |
| Gross profit | −$41,530 | −$129,094 | $0 | $0 | — | −$391,416 |
| Research & development | $24.5M | $537,428 | $2.7M | $4.2M | $8.4M | $15.5M |
| Sales, general & admin | $7.80B | $17.9M | $24.6M | $15.3M | $14.3M | — |
| Total operating expenses | $7.8M | $18.4M | $81.6M | $38.6M | $116.1M | $23.0M |
| Operating income | −$7.9M | −$18.5M | −$81.6M | −$38.6M | −$116.1M | −$23.4M |
| Interest income | — | $116,346 | — | — | $122,041 | — |
| Interest expense | $235,074 | $725,684 | $2.4M | $706,964 | $372,844 | $379,608 |
| Income before taxes | −$3.6M | −$178.0M | −$88.4M | −$39.7M | −$113.4M | −$26.8M |
| Income taxes | — | — | — | — | $34 | −$125,276 |
| Net income | −$3.56B | −$178.0M | −$88.4M | −$39.7M | −$113.4M | −$26.7M |
| EBITDA | −$7.8M | −$177.2M | −$85.9M | −$38.9M | −$112.9M | −$26.1M |
| EPS (diluted) | −$0.05 | −$29.34 | −$71.95 | −$42.09 | −$136.64 | −$0.56 |
| Gross margin | −79.9% | — | — | — | — | — |
| Operating margin | −15,129.3% | — | — | — | — | — |
| Net margin | −6,851,975.3% | — | — | — | — | — |
| Sep '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $31,050 | $20,942 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $29,667 | $11,000 | $11,332 | $41,522 | $32,626 | $0 | — | — | — | $30,305 | $33,162 |
| Gross profit | $1,383 | $9,941 | −$11,332 | −$41,522 | −$32,626 | $0 | — | — | — | −$30,305 | −$33,162 |
| Research & development | $24.4M | $15,945 | $45,872 | $24,407 | $80,228 | $94,073 | $161,084 | $390,189 | $434,508 | $1.1M | $620,521 |
| Sales, general & admin | — | $1.4M | $1.8M | $2.4M | $4.0M | $4.2M | $4.4M | $5.3M | $5.0M | — | — |
| Total operating expenses | $2.1M | $1.4M | $1.8M | $2.4M | $4.1M | $4.2M | $4.5M | $53.3M | $51.3M | $8.7M | $4.2M |
| Operating income | −$2.1M | −$1.4M | −$1.8M | −$2.5M | −$4.1M | −$4.2M | −$4.5M | −$53.3M | −$51.3M | −$8.8M | −$4.3M |
| Interest income | — | — | $5,518 | $33,297 | $6,863 | $72 | — | $126,598 | — | — | — |
| Interest expense | $183,171 | $108,052 | $121,508 | $188,685 | $188,028 | $188,685 | $116,078 | $250,080 | $1.7M | $303,802 | $274,984 |
| Income before taxes | −$2.0M | −$2.6M | −$1.8M | $2.8M | −$126.7M | $189,176 | −$7.3M | −$44.2M | −$49.9M | −$59.0M | −$4.5M |
| Net income | −$2.0M | −$2.6M | −$1.8M | $2.8M | −$126.7M | $189,176 | −$7.3M | −$44.2M | −$49.9M | −$59.0M | −$4.5M |
| EBITDA | −$2.1M | −$2.4M | −$1.7M | $3.0M | −$126.5M | $409,836 | −$7.1M | −$43.9M | −$48.2M | −$58.7M | −$4.2M |
| EPS (diluted) | — | −$0.10 | −$0.08 | $0.13 | −$7.20 | $0.01 | −$0.04 | −$22.11 | −$11.87 | −$43.20 | −$5.50 |
| Gross margin | 4.5% | 47.5% | — | — | — | — | — | — | — | — | — |
| Operating margin | −6,888.6% | −6,815.3% | — | — | — | — | — | — | — | — | — |
| Net margin | −6,475.7% | −12,278.6% | — | — | — | — | — | — | — | — | — |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in LNAI's financial statements (latest annual report filed October 13, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
LNAI financial results
In fiscal year 2026 (ended June 30, 2026), Lunai Bioworks reported revenue of $0.1 million. It had a net loss of $3.6 billion, a net profit margin of −6,851,975.3%. Diluted earnings per share came to −$0.05.
See the LNAI stock overview for the latest quote and news, or the LNAI chart for price history and technical indicators.
LNAI income statement FAQ
What is Lunai Bioworks's annual revenue?
Lunai Bioworks reported total revenue of $0.1 million for fiscal year 2026, which ended on June 30, 2026.
Is Lunai Bioworks profitable?
No. Lunai Bioworks reported a net loss of $3.6 billion in fiscal 2026, a net profit margin of −6,851,975.3%; its operating margin was −15,129.3%.
What is Lunai Bioworks's gross margin?
Lunai Bioworks's gross margin was −79.9% in fiscal 2026: for every $100 of revenue, Lunai Bioworks kept $-80 after the direct cost of its products and services.
How much does Lunai Bioworks spend on research and development?
Lunai Bioworks spent $24.5 million on research and development in fiscal 2026, 47,157.3% of revenue.
What are Lunai Bioworks's earnings per share?
Lunai Bioworks earned $-0.05 per diluted share in fiscal 2026, compared with $-29.34 a year earlier.
When will Lunai Bioworks report its next earnings?
Lunai Bioworks is expected to report results for the quarter ending September 30, 2026 on November 13, 2026.
When does Lunai Bioworks's fiscal year end?
Lunai Bioworks's fiscal year ends in June. The latest annual report covers the year ended June 30, 2026 and was filed on October 13, 2026.